Benitec Biopharma Inc. Common Stock
€9.967
EUR
Last updated on --.
24h volume57.57K
24h highest10.3244 EUR
24h lowest9.8728 EUR
24h Price movement+1.22%
BNTC recent prices
24 Hours
+1.22%+€0.1204
30 days
-4.03%-€0.4214
60 days
+16.10%+€1.393
90 days
+7.16%+€0.6708
Key data
Previous close9.8470 EUR
Market cap324.70M EUR
Volume57.57K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-1.2212 EUR
Net income (FY)-42.04M EUR
Revenue (FY)--
Last report date14 May 2026
About Benitec Biopharma Inc. Common Stock
HeadquartersHAYWARD
Employees (FY)19.00
Net income per employee (FY)-2.21M EUR
Listed onNasdaq
BNTC conversion tables
 |  |
|---|---|
| 0.5 BNTC | 4.983 EUR |
| 1 BNTC | 9.967 EUR |
| 5 BNTC | 49.83 EUR |
| 10 BNTC | 99.67 EUR |
| |
|---|---|
| 0.5 EUR | 0.050164 BNTC |
| 1 EUR | 0.10033 BNTC |
| 5 EUR | 0.50164 BNTC |
| 10 EUR | 1.003 BNTC |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
BNTC is trading at €9.967, +1.22% over the last 24 hours. Track live moves on the price chart at the top of this page.
The BNTC stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. BNTC is currently trading at €9.967, +1.22% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on BNTC price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. BNTC's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from BNTC; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against BNTC's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Benitec Biopharma Inc. Common Stock's market cap is currently 324.70M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume57.57K
24h highest10.3244 EUR
24h lowest9.8728 EUR
24h Price movement+1.22%
Start trade with BNTC Perpetual
Sign up to trade